Ablations of Human and Murine TNK2/ACK1 Proteins Do Not Alter Influenza A Virus Infections In Vitro or In Vivo
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Sisi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Orthomyxoviridae Infections, Influenza A virus, Influenza, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: This study was supported by the following: the National Natural Science Foundation of China grants (No. 32270158, 82341054), and Shenzhen Medical Research Fund….
Abstract (Originalsprache)
Tyrosine kinase non‐receptor2 (TNK2) is a host protein involved in vesicular trafficking, cell spreading, migration, survival, and proliferation. TNK2 has been identified as a conserved host factor for the entry of several non‐enveloped RNA viruses, such as Orsay virus in Caenorhabditis elegans and multiple picornaviruses in cells and mice. Although TNK2 was reported as required for influenza A virus infection in a genome‐wide CRISPR screen, its role remains contentious as it was not identified in other screens. In this study, we comprehensively evaluated TNK2's function in IAV infection using in vitro and in vivo models. RNAi knockdown and CRISPR knockout of TNK2 in multiple cells showed no significant reduction in IAV infection. Similarly, primary lung fibroblasts and bone marrow–derived macrophages from Tnk2 ‐/‐ mice exhibited comparable infection to those from Tnk2 +/+ mice. Moreover, Tnk2 ‐/‐ mice exhibited no differences in weight loss, survival, lung pathology, or viral load compared to those of Tnk2 +/+ mice after IAV infection. Furthermore, the expression of interferon‐β and interferon‐stimulated genes were not significantly altered in Tnk2 ‐/‐ mice compared to that of Tnk2 +/+ mice. Together, these results indicate that TNK2 is not a dominant host factor for IAV infection, suggesting it may not be a viable therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, Guangdong, China.
- Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen, Guangdong, China.
- Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China.
- Department of Pathophysiology, College of High-Altitude Military Medicine Army Medical University (Third Military Medical University), Chongqing, China.
ORCID-Profile: Hongbing Jiang
Förderung
- This study was supported by the following: the National Natural Science Foundation of China grants (No. 32270158, 82341054), and Shenzhen Medical Research Fund…
Zitieren
APA
Liu, S., Fang, Y., Li, L., Huo, J., Liu, B., Wang, J., Xu, J., Song, F., Li, H., & Jiang, H. (2025). Ablations of Human and Murine TNK2/ACK1 Proteins Do Not Alter Influenza A Virus Infections In Vitro or In Vivo. Journal of Medical Virology. https://doi.org/10.1002/jmv.70592
Vancouver
Liu S, Fang Y, Li L, Huo J, Liu B, Wang J, et al. Ablations of Human and Murine TNK2/ACK1 Proteins Do Not Alter Influenza A Virus Infections In Vitro or In Vivo. Journal of Medical Virology. 2025. doi:10.1002/jmv.70592
BibTeX
@article{Liu2025,
author = {Liu, Sisi and Fang, Yiqun and Li, Lingyu and Huo, Jingwen and Liu, Binyi and Wang, Jianhao and Xu, Jimin and Song, Fangzhou and Li, Haiyu and Jiang, Hongbing},
title = {Ablations of Human and Murine TNK2/ACK1 Proteins Do Not Alter Influenza A Virus Infections In Vitro or In Vivo},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70592}
}
EUVIMED